Particularly, renal cell carcinoma (RCC) were associated with fewer rate of mucositis (RR 1) than astrocytoma (RR 5.29), gastric cancer or breast cancer, regardless the combination of mTOR-inhibitors with other drugs. This evidence concerns the gene MTOR and renal cell adenocarcinoma.